gelafusal
biomed limited - gelatin (as 40 g/l gelatin polysuccinate); succinic anhydride (as 40 g/l gelatin polysuccinate); succinylated gelatin 40 g/l (gelatin polysuccinate created during product manufacture from gelatin and succinic anhydride); ; ; ; ; - solution for infusion - 40 g/l - active: gelatin (as 40 g/l gelatin polysuccinate) succinic anhydride (as 40 g/l gelatin polysuccinate) succinylated gelatin 40 g/l (gelatin polysuccinate created during product manufacture from gelatin and succinic anhydride) excipient: calcium chloride dihydrate hydrochloric acid magnesium chloride hexahydrate potassium chloride sodium acetate trihydrate sodium chloride sodium hydroxide water for injection
valdoxan tablet 25mg
servier (s) pte ltd - agomelatine - tablet, film coated - 25 mg - agomelatine 25 mg
volplex 4% infusion 500ml bags
kent pharma (uk) ltd - gelatin - infusion - 40mg/1ml
volplex 4% infusion 1litre bags
kent pharma (uk) ltd - gelatin - infusion - 40mg/1ml
isoplex 4% infusion 500ml bags
kent pharma (uk) ltd - gelatin - infusion - 40mg/1ml
isoplex 4% infusion 1litre bags
beacon pharmaceuticals ltd - gelatin - infusion - 40mg/1ml
valdoxan 25mg film-coated tablets
servier malaysia sdn bhd - agomelatine -
gelofusine 4 % inf. sol. i.v.
b. braun melsungen ag - sodium chloride 3,016 g - 5,225 g; gelatin sponge 40 mg - solution for infusion - 4 % - gelatin, modified 40 mg/ml; sodium chloride 3.54 mg/ml - gelatin agents
gelatamp - gelatin haemostatic agent
henry schein halas - 48170 - gelatin haemostatic agent - a haemostatic gelatine sponge with 5 % colloidal silver (14 x 7 x 7mm) that can be cut to the required size. the sponge absorbs its own weight in blood several times over, promotes thrombocyte aggregation & fills the wound cavity. the plug formed has a constant volume & stabilises blood coagulum to prevent the formation of fissures & secondary cavities. gelatamp remains in the wound & is completely absorbed within 4 weeks. the colloidal silver has an antimicrobial effect. gamma-sterilised. for use in dental surgery for the treatment of alveoli and wound cavities, e.g. after extractions, cystectomies, cystostomies, apical amputations, maxillary sinus perforations, following surgical removal of tumours or retained teeth. prevention of secondary cavity formation. prophylaxis of wound infections. secondary haemorrhage prophylaxis. as a dressing after gingivectomy and in periodontopathies.
gelfoam sponge - gelatin haemostatic agent
pfizer australia pty ltd - 48170 - gelatin haemostatic agent - processes, sterile, porcine skin gelatin sponge applied during or after surgery to stop bleeding. the device is absorbed by the body. haemostatic sterile absorbable device (sponge) for use as an agent to stop bleeding during surgical procedures.